Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo With Long Term Follow Up after successful Trial Without Catheter In Acute Urinary Retention
Phase of Trial: Phase I
Latest Information Update: 11 Dec 2012
At a glance
- Drugs Alfuzosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 11 Dec 2012 Status changed from suspended to completed as reported by Chinese Clinical Trial Register record.
- 21 May 2012 Planned end date (31 May 2014) added as reported by Chinese Clinical Trial Register record.
- 08 May 2012 New trial record